Brain Tumors

Pituitary Surgery

Pituitary Surgery: Inpatient Mortality

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality. solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software.

There has been no surgical inpatient mortality following pituitary surgery for the past 5 years.

Pituitary Surgery: Length of Stay

LOS = length of stay

ᵃThe 3M™ All Patient Refined Diagnosis Related Groups (APR-DRG) Classification System is used for adjusting data for severity of illness and risk of mortality. solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software.

Following pituitary surgery, actual LOS has been close to expected LOS for the past 5 years.

Pituitary Surgery: Survival

The 30- and 180-day survival rates following pituitary surgery were 98.8% and 97.5%, respectively (for the first 6 months of 2017). N = number of pituitary tumor surgeries per year, based on available data.

Pituitary Surgery: Karnofsky Performance Scale (N = 64)

2017

Functional status is measured by the Karnofsky Performance Scale (KPS), a widely used 11-point scale correlating to percentage values from 100% (no evidence of disease, no symptoms) to 0% (death). Performance status, as measured by the Karnofsky Performance Scale (KPS), was stable or improved in 89% of patients within 30 days of pituitary surgery. Change in KPS status was defined as a change of ≥ 20 points.